MARX Biotech Co., Ltd.(TW:7731)
NT$4.26-0.09 (-2.07%)
TW:7731
MARX Biotech Co., Ltd. Revenue
NT$4.26
At close:-0.09 (-2.07%)
MARX Biotech Co., Ltd. (7731) Revenue
MARX Biotech Co., Ltd. Revenue
MARX Biotech Co., Ltd. had a revenue of 257.81M in the quarter ending Jun 30, 2026, with 100.00%. This bring the company's revenue in the last twelve months to 877.11M, Increased 13.36%. In the fiscal year ending Dec 31, 2025, MARX Biotech Co., Ltd. had annual revenue of 635.85M with 2.85% growth.
- Revenue (ttm)
- 877.11M
- Revenue Growth
- -17.97%
- P/S Ratio
- 3.69
- Revenue/Employee
- TWD 7,948,150
- Employees
- 80
- Market Cap
- TWD 2.35B
Revenue Chart
MARX Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 635.85M | 17.63M | 2.85% |
| Dec 31, 2024 | 618.23M | 328.30M | 113.24% |
| Dec 31, 2023 | 289.93M | 179.28M | 162.04% |
| Dec 31, 2022 | 110.64M | 13.04M | 13.35% |
| Dec 31, 2021 | 97.61M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.